Evidence map›Paper›PMID 40981991›Full record

ArticleEuropean radiology2026

Deep-learning-based prediction of significant portal hypertension with single cross-sectional non-enhanced CT.

Akira Yamamoto, Shingo Sato, Daiju Ueda, Shannon L Walston, Ken Kageyama, Atsushi Jogo, Mariko Nakano, Kohei Kotani, Sawako Uchida-Kobayashi, Norifumi Kawada and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Akira YamamotoDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan. loveakirayamamoto@gmail.com.ORCID http://orcid.org/0000-0002-4567-9745
Shingo SatoDepartment of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
Daiju UedaDepartment of Artificial Intelligence, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Shannon L WalstonDepartment of Artificial Intelligence, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Ken KageyamaDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Atsushi JogoDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Mariko NakanoDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Kohei KotaniDepartment of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Sawako Uchida-KobayashiDepartment of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Norifumi KawadaDepartment of Hepatology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Yukio MikiDepartment of Diagnostic and Interventional Radiology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.

Funding

Kakenhi JP22K07752
6 · The paper itself

Abstract

objectivesThe purpose of this study was to establish a predictive deep learning (DL) model for clinically significant portal hypertension (CSPH) based on a single cross-sectional non-contrast CT image and to compare four representative positional images to determine the most suitable for the detection of CSPH. MATERIALS AND

methodsThe study included 421 patients with chronic liver disease who underwent hepatic venous pressure gradient measurement at our institution between May 2007 and January 2024. Patients were randomly classified into training, validation, and test datasets at a ratio of 8:1:1. Non-contrast cross-sectional CT images from four target areas of interest were used to create four deep-learning-based models for predicting CSPH. The areas of interest were the umbilical portion of the portal vein (PV), the first right branch of the PV, the confluence of the splenic vein and PV, and the maximum cross-section of the spleen. The models were implemented using convolutional neural networks with a multilayer perceptron as the classifier. The model with the best predictive ability for CSPH was then compared to 13 conventional evaluation methods.

resultsAmong the four areas, the umbilical portion of the PV had the highest predictive ability for CSPH (area under the curve [AUC]: 0.80). At the threshold maximizing the Youden index, sensitivity and specificity were 0.867 and 0.615, respectively. This DL model outperformed the ANTICIPATE model.

conclusionWe developed an algorithm that can predict CSPH immediately from a single slice of non-contrast CT, using the most suitable image of the umbilical portion of the PV. KEY POINTS: Question CSPH predicts complications but requires invasive hepatic venous pressure gradient measurement for diagnosis. Findings At the threshold maximizing the Youden index, sensitivity and specificity were 0.867 and 0.615, respectively. This DL model outperformed the ANTICIPATE model. Clinical relevance This study shows that a DL model can accurately predict CSPH from a single non-contrast CT image, providing a non-invasive alternative to invasive methods and aiding early detection and risk stratification in chronic liver disease without image manipulation.

Indexed as

Deep LearningHypertension, PortalTomography, X-Ray ComputedAdultAgedFemaleHumansMaleMiddle AgedPortal VeinPredictive Value of TestsRadiographic Image Interpretation, Computer-AssistedRetrospective StudiesSensitivity and SpecificityDeep leaningHepatic venous-portal gradientLiver diseaseNon-enhanced CTPortal hypertension

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.